Atai Life Sciences Pre-Tax Profit Margin 2020-2025 | ATAI
Atai Life Sciences pre-tax profit margin from 2020 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Atai Life Sciences Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2025-03-31 |
$0.00B |
$-0.15B |
-7400.00% |
2024-09-30 |
$0.00B |
$-0.13B |
0.00% |
2024-06-30 |
$0.00B |
$-0.06B |
0.00% |
2023-12-31 |
$0.00B |
$-0.04B |
0.00% |
2023-09-30 |
$0.00B |
$-0.06B |
0.00% |
2023-06-30 |
$0.00B |
$-0.14B |
0.00% |
2023-03-31 |
$0.00B |
$-0.14B |
0.00% |
2022-09-30 |
$0.00B |
$-0.15B |
0.00% |
2022-06-30 |
$0.00B |
$-0.14B |
0.00% |
2021-12-31 |
$0.02B |
$-0.14B |
-680.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.405B |
$0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|